Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
After a blood cancer diagnosis, one Arkansas endurance cyclist is back on his bike — just 13 months after treatment, he's ...
A private hospital in Bengaluru successfully performs day-care bone marrow transplants, reducing costs and treatment duration for select blood cancer patients.
New AI research tool can predict plasma cell cancer outcomes instantly by reading standard biopsy slides, boosting precision ...
C. Ola Landgren, M.D., Ph.D., received HealthTree Foundation's prestigious 2025 Innovation Award for his work in developing CORAL, a new research tool that leverages AI to predict individual outcomes ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...
Cancer-Fighting Cells Engineered Inside Patients’ Bodies Rather Than Laboratory for the First Time
Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...
Drs Joseph Mikhael and Shaji Kumar discuss the future of multiple myeloma, including enhanced diagnostics for detecting ...
The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.
Researchers have uncovered differences in how multiple myeloma develops and progresses in men and in women, which could lead ...
At the 2025 ASH Annual Meeting and Exposition, researchers presented new findings that may meaningfully affect how patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback